The Harmony Trial: Baseline Characteristics From a Phase 1/2 Trial of ADP101 for Oral Immunotherapy in Children and Adults With Single or Multiple Food Allergies

ADP101 - Alladapt Immunotherap

Shaila Gogate; Mei-Lun Wang; Amy Sullivan; Nusrat Rabbee; Ashley Dombkowski; Dana Mcclintock

Apr 30, 2023